These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17055740)

  • 1. Formation of well-defined soluble aggregates upon fusion to MBP is a generic property of E6 proteins from various human papillomavirus species.
    Zanier K; Nominé Y; Charbonnier S; Ruhlmann C; Schultz P; Schweizer J; Travé G
    Protein Expr Purif; 2007 Jan; 51(1):59-70. PubMed ID: 17055740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of soluble inclusion bodies by hpv e6 oncoprotein fused to maltose-binding protein.
    Nominé Y; Ristriani T; Laurent C; Lefèvre JF; Weiss E ; Travé G
    Protein Expr Purif; 2001 Oct; 23(1):22-32. PubMed ID: 11570842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E6*, the 50 amino acid product of the most abundant spliced transcript of the e6 oncoprotein in high-risk human papillomavirus, is a promiscuous folder and binder.
    Heer A; Alonso LG; de Prat-Gay G
    Biochemistry; 2011 Mar; 50(8):1376-83. PubMed ID: 21226480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV oncoprotein E6 is a structure-dependent DNA-binding protein that recognizes four-way junctions.
    Ristriani T; Masson M; Nominé Y; Laurent C; Lefevre JF; Weiss E; Travé G
    J Mol Biol; 2000 Mar; 296(5):1189-203. PubMed ID: 10698626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific recognition of four-way DNA junctions by the C-terminal zinc-binding domain of HPV oncoprotein E6.
    Ristriani T; Nominé Y; Masson M; Weiss E; Travé G
    J Mol Biol; 2001 Jan; 305(4):729-39. PubMed ID: 11162088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chelating agents stabilize the monomeric state of the zinc binding human papillomavirus 16 E6 oncoprotein.
    Degenkolbe R; Gilligan P; Gupta S; Bernard HU
    Biochemistry; 2003 Apr; 42(13):3868-73. PubMed ID: 12667077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A strategy for optimizing the monodispersity of fusion proteins: application to purification of recombinant HPV E6 oncoprotein.
    Nominé Y; Ristriani T; Laurent C; Lefèvre JF; Weiss E ; Travé G
    Protein Eng; 2001 Apr; 14(4):297-305. PubMed ID: 11391022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A C-terminal hydrophobic, solvent-protected core and a flexible N-terminus are potentially required for human papillomavirus 18 E7 protein functionality.
    Liu S; Tian Y; Greenaway FT; Sun MZ
    Biochimie; 2010 Jul; 92(7):901-8. PubMed ID: 20211680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-risk HPV E6 oncoproteins assemble into large oligomers that allow localization of endogenous species in prototypic HPV-transformed cell lines.
    García-Alai MM; Dantur KI; Smal C; Pietrasanta L; de Prat-Gay G
    Biochemistry; 2007 Jan; 46(2):341-9. PubMed ID: 17209544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-assembly properties of recombinant engineered amelogenin proteins analyzed by dynamic light scattering and atomic force microscopy.
    Moradian-Oldak J; Paine ML; Lei YP; Fincham AG; Snead ML
    J Struct Biol; 2000 Jul; 131(1):27-37. PubMed ID: 10945967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A structural requirement of zinc for the folding of recombinant link protein.
    Varelas JB; Roy C; Hering TM
    Arch Biochem Biophys; 1997 Nov; 347(1):1-8. PubMed ID: 9344458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein.
    Zhang Y; Dasgupta J; Ma RZ; Banks L; Thomas M; Chen XS
    J Virol; 2007 Apr; 81(7):3618-26. PubMed ID: 17267502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein mutagenesis with monodispersity-based quality probing: selective inactivation of p53 degradation and DNA-binding properties of HPV E6 oncoprotein.
    Ristriani T; Nominé Y; Laurent C; Weiss E; Travé G
    Protein Expr Purif; 2002 Dec; 26(3):357-67. PubMed ID: 12460759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis.
    Nominé Y; Masson M; Charbonnier S; Zanier K; Ristriani T; Deryckère F; Sibler AP; Desplancq D; Atkinson RA; Weiss E; Orfanoudakis G; Kieffer B; Travé G
    Mol Cell; 2006 Mar; 21(5):665-78. PubMed ID: 16507364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E6 protein of human papillomavirus 16 (HPV16) expressed in Escherichia coli sans a stretch of hydrophobic amino acids, enables purification of GST-ΔE6 in the soluble form and retains the binding ability to p53.
    Verma RR; Sriraman R; Rana SK; Ponnanna NM; Rajendar B; Ghantasala P; Rajendra L; Matur RV; Srinivasan VA
    Protein Expr Purif; 2013 Nov; 92(1):41-7. PubMed ID: 24012792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-step affinity purification of fusion proteins with optimal monodispersity and biological activity: application to aggregation-prone HPV E6 proteins.
    Bonhoure A; Demenge A; Kostmann C; San José L; De la Cal E; Armisen P; Nominé Y; Travé G
    Microb Cell Fact; 2018 Dec; 17(1):191. PubMed ID: 30501645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus.
    Liu Y; Liu Z; Androphy E; Chen J; Baleja JD
    Biochemistry; 2004 Jun; 43(23):7421-31. PubMed ID: 15182185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving solubility of Shewanella oneidensis MR-1 and Clostridium thermocellum JW-20 proteins expressed into Esherichia coli.
    Kataeva I; Chang J; Xu H; Luan CH; Zhou J; Uversky VN; Lin D; Horanyi P; Liu ZJ; Ljungdahl LG; Rose J; Luo M; Wang BC
    J Proteome Res; 2005; 4(6):1942-51. PubMed ID: 16335938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Domain substructure of HPV E6 oncoprotein: biophysical characterization of the E6 C-terminal DNA-binding domain.
    Nominé Y; Charbonnier S; Ristriani T; Stier G; Masson M; Cavusoglu N; Van Dorsselaer A; Weiss E; Kieffer B; Travé G
    Biochemistry; 2003 May; 42(17):4909-17. PubMed ID: 12718532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression, purification, and serum antibody detection of HPV16 E6 in cervical cancer patients].
    Gao YE; Guo JZ; Zhang J; Song TB; Yan XJ
    Ai Zheng; 2006 Nov; 25(11):1374-9. PubMed ID: 17094904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.